BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9477370)

  • 21. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignancy in uremia: dialysis versus transplantation.
    Herr HW; Engen DE; Hostetler J
    J Urol; 1979 May; 121(5):584-6. PubMed ID: 374755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. De novo cancer in patients on dialysis and after renal transplantation: north-western Italy, 1997-2012.
    Mazzucotelli V; Piselli P; Verdirosi D; Cimaglia C; Cancarini G; Serraino D; Sandrini S
    J Nephrol; 2017 Dec; 30(6):851-857. PubMed ID: 28317077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of viral hepatitis in solid organ transplantation].
    Mikolašević I; Sladoje-Martinović B; Orlić L; Milić S; Lukenda V; Župan Ž; Štimac D; Rački S
    Acta Med Croatica; 2014 Apr; 68(2):151-9. PubMed ID: 26012153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
    Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA
    Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumours after kidney transplantation.
    Lutz J; Heemann U
    Curr Opin Urol; 2003 Mar; 13(2):105-9. PubMed ID: 12584469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant tumours in renal transplant recipients receiving cyclosporin: survey of 598 first-kidney transplantations.
    Vogt P; Frei U; Repp H; Bunzendahl H; Oldhafer K; Pichlmayr R
    Nephrol Dial Transplant; 1990; 5(4):282-8. PubMed ID: 2113225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.
    Kuo PC; Luikart H; Busse-Henry S; Hunt SA; Valantine HA; Stinson EB; Oyer PE; Scandling JD; Alfrey EJ; Dafoe DC
    Clin Transplant; 1995 Apr; 9(2):92-7. PubMed ID: 7599409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer incidence in patients on chronic dialysis and in renal transplant recipients.
    Pecqueux JC; Schwarz A; Dieckmann KP; Offermann G
    Urol Int; 1990; 45(5):290-2. PubMed ID: 2219566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kidney transplantation and tumours.
    Forslund T; Kock B; Kuhlbäck B
    Ann Clin Res; 1980 Apr; 12(2):55-8. PubMed ID: 7004326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant tumours following immunosuppression in renal transplantation.
    Birkeland SA; Kemp E
    Proc Eur Dial Transplant Assoc; 1973; 10(0):429-33. PubMed ID: 4370181
    [No Abstract]   [Full Text] [Related]  

  • 32. The management of transitional cell carcinoma (TCC) in a European regional renal transplant population.
    Rogers A; Ng JK; Glendinning J; Rix D
    BJU Int; 2012 Jul; 110(2 Pt 2):E34-40. PubMed ID: 22243691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early de novo malignancies after kidney transplantation.
    Veroux M; Puliatti C; Fiamingo P; Cappello D; Macarone M; Puliatti D; Vizcarra D; Gagliano M; Veroux P
    Transplant Proc; 2004 Apr; 36(3):718-20. PubMed ID: 15110643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer incidence after immunosuppressive treatment following kidney transplantation.
    Andrés A
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):71-85. PubMed ID: 15978827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weaning of immunosuppression in liver transplant recipients.
    Mazariegos GV; Reyes J; Marino IR; Demetris AJ; Flynn B; Irish W; McMichael J; Fung JJ; Starzl TE
    Transplantation; 1997 Jan; 63(2):243-9. PubMed ID: 9020325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
    Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
    BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melanomas in renal transplant recipients.
    Le Mire L; Hollowood K; Gray D; Bordea C; Wojnarowska F
    Br J Dermatol; 2006 Mar; 154(3):472-7. PubMed ID: 16445778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risk of cancer in patients following chronic dialysis and kidney graft].
    Janus N; Launay-Vacher V; Ferrero JM; Thariat J
    Bull Cancer; 2012 Mar; 99(3):285-93. PubMed ID: 22381360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The utility of 6-month protocol renal biopsy under modern immunosuppression.
    Yango A; Gohh R; Wang LJ; Morrissey P; Shih M; Lowery K; Charpentier K; Gautam A; Mendonca C; Kumar S; Dworkin L; Monaco A
    Clin Nephrol; 2008 Dec; 70(6):490-5. PubMed ID: 19049705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical course of malignancies in renal transplant recipients.
    Barrett WL; First MR; Aron BS; Penn I
    Cancer; 1993 Oct; 72(7):2186-9. PubMed ID: 8374876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.